首页> 外文OA文献 >Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

【2h】

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

机译：口腔药用大麻素可缓解癌症患者姑息治疗的症状负担：一种双盲，安慰剂控制，随机临床试验，疗效和安全性为1：1δ-9-四氢胺（THC）和大麻（CBD）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Janet Hardy; Alison Haywood; Gauri Gogna; Jennifer Martin; Patsy Yates; Ristan Greer; Phillip Good;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) [J] . Janet Hardy, Alison Haywood, Gauri Gogna, Trials . 2020 ,第1期

机译：口腔药用大麻素可缓解癌症患者姑息治疗的症状负担：一种双盲，安慰剂控制，随机临床试验，疗效和安全性为1：1δ-9-四氢胺（THC）和大麻（CBD）
2. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) [J] . Phillip Good, Alison Haywood, Gauri Gogna, BMC Palliative Care . 2019 ,第1期

机译：口腔药物大麻素减轻癌症患者姑息治疗的症状负担：一种双盲，安慰剂控制，随机临床试验，疗效和安全性的疗效和安全性（CBD）
3. A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. [J] . Bruera E, Sloan P, Mount B, Journal of Clinical Oncology . 1996 ,第5期

机译：一项随机，双盲，双模拟，交叉试验比较了口服持续释放氢吗啡酮与即释氢吗啡酮在癌症疼痛患者中的安全性和有效性。加拿大姑息治疗临床试验小组。
4. Communication preferences, expectations of benefit, and symptom burdens among advanced cancer patients and partners during patient participation in phase I trials [D] . Hlubocky, Fay J. 2010

机译：患者参加I期试验期间，晚期癌症患者及其伴侣之间的沟通偏好，受益期望以及症状负担
5. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind placebo controlled randomised clinical trial of efficacy and safety of cannabidiol (CBD) [O] . Phillip Good, Alison Haywood, Gauri Gogna, 2019

机译：口服药用大麻素可减轻晚期癌症患者的姑息治疗中的症状负担：大麻双酚（CBD）疗效和安全性的双盲安慰剂对照随机临床试验
6. The effects of an Ayurvedic medicinal toothpaste on clinical, microbiological and oral hygiene parameters in patients with chronic gingivitis: a double-blind, randomised, placebo-controlled, parallel allocation clinical trial [O] . J. Howshigan, K. Perera, S. Samita, 2016

机译：阿育吠陀药用牙膏对慢性牙龈炎患者临床，微生物和口服卫生参数的影响：双盲，随机，安慰剂控制，平行分配临床试验

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

著录项

相似文献

相关主题

期刊订阅